-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Prostate cancer (Image source: hopkinsmedicine.
June 30, 2021/Bio Valley BIOON/ - Novartis recently announced that the results of a key Phase 3 VISION study evaluating targeted radioligand therapy 177Lu-PSMA-617 for the treatment of prostate cancer have been published in New England Medicine Magazine (NEJM)